Avadel Pharmaceuticals PLC (AVDL)
11.56
-0.46
(-3.83%)
USD |
NASDAQ |
Nov 14, 12:52
Avadel Pharmaceuticals Debt to Equity Ratio: 0.00 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2024 | 0.00 |
March 31, 2024 | 0.00 |
December 31, 2023 | 0.00 |
September 30, 2023 | 0.1923 |
June 30, 2023 | 0.1456 |
March 31, 2023 | -2.978 |
December 31, 2022 | -6.114 |
September 30, 2022 | -10.95 |
June 30, 2022 | -40.31 |
March 31, 2022 | 2.584 |
December 31, 2021 | 1.820 |
September 30, 2021 | 1.436 |
June 30, 2021 | 1.193 |
March 31, 2021 | 1.036 |
December 31, 2020 | 0.7901 |
September 30, 2020 | 0.739 |
June 30, 2020 | 0.6857 |
March 31, 2020 | 3.844 |
December 31, 2019 | -4.168 |
September 30, 2019 | -4.457 |
June 30, 2019 | -6.679 |
March 31, 2019 | -12.24 |
December 31, 2018 | 41.67 |
September 30, 2018 | 1.742 |
June 30, 2018 | 1.440 |
Date | Value |
---|---|
March 31, 2018 | 1.285 |
December 31, 2017 | 0.0031 |
September 30, 2017 | 0.0095 |
June 30, 2017 | 0.0115 |
March 31, 2017 | 0.014 |
December 31, 2016 | 0.0194 |
September 30, 2016 | 0.0277 |
June 30, 2016 | 0.0207 |
March 31, 2016 | 0.0167 |
December 31, 2015 | 0.0162 |
September 30, 2015 | |
June 30, 2015 | 10.98 |
March 31, 2015 | 5.537 |
December 31, 2014 | 0.1493 |
September 30, 2014 | 2.393 |
June 30, 2014 | 1.511 |
March 31, 2014 | 0.9556 |
December 31, 2013 | -8.990 |
September 30, 2013 | -5.567 |
June 30, 2013 | -8.423 |
March 31, 2013 | 2.492 |
December 31, 2012 | 1.201 |
September 30, 2012 | |
June 30, 2012 | 1.964 |
March 31, 2012 | 1.559 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-40.31
Minimum
Jun 2022
3.844
Maximum
Mar 2020
-2.634
Average
0.1923
Median
Sep 2023
Debt to Equity Ratio Benchmarks
Jazz Pharmaceuticals PLC | 1.465 |
Medtronic PLC | 0.5801 |
Alkermes PLC | 0.2235 |
Perrigo Co PLC | 1.041 |
Iterum Therapeutics PLC | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 157.52M |
Total Liabilities (Quarterly) | 87.23M |
Shareholders Equity (Quarterly) | 70.29M |
Current Ratio | 2.819 |
Net Debt Paydown Yield | 1.68% |